NCALD

NCALD (neurocalcin delta) is a 22 kDa neuronal calcium sensor protein, expressed most abundantly in brain and identified by cloning of the human gene with near-complete conservation to bovine and chicken orthologs (PMID:11267673). Its best-defined biological role is as an SMN-independent disease modifier of spinal muscular atrophy: antisense oligonucleotide-mediated reduction of NCALD by >70% in a severe SMA mouse model ameliorates neuromuscular junction electrophysiology and histology, muscle integrity, and motor deficits (PMID:31230718). In the hippocampus, loss- and gain-of-function studies place NCALD upstream of pro-inflammatory IKK/IκBα/NF-κB signaling, where silencing reduces p-IKKβ, p-IκBα, and nuclear NF-κB p65 along with downstream cytokines (IL-1β, IL-6, TNF-α, COX-2, iNOS) (PMID:33578182). Beyond these roles, the molecular activity of NCALD as a calcium sensor and its direct effector partners have not been mechanistically resolved in the available corpus.

1. 2001 Medium

   Established the identity, tissue distribution, and chromosomal location of human NCALD, defining it as a highly conserved 22 kDa neurocalcin delta protein and providing the molecular entry point for all later functional work.

   Evidence cDNA cloning from human fetal brain library with Northern blot, in situ hybridization, and radiation hybrid mapping

   PMID:11267673

   Open questions at the time

   • No biochemical demonstration of calcium-sensing activity
   • No interaction partners or downstream effectors identified
   • Subcellular localization not resolved
2. 2019 High

   Answered whether NCALD has therapeutic relevance in disease by showing its reduction rescues SMA pathology independent of SMN, defining NCALD as a bona fide disease modifier and a tractable target.

   Evidence ASO-mediated knockdown in a severe SMA mouse model with randomized-blinded electrophysiology, histology, and motor behavioral readouts

   PMID:31230718

   Open questions at the time

   • Molecular mechanism by which NCALD reduction protects the neuromuscular junction is not defined
   • No direct NCALD effector linking it to SMA pathology identified
   • Whether the protective effect depends on NCALD calcium-sensing activity is untested
3. 2021 Medium

   Addressed how NCALD influences hippocampal pathology by placing it upstream of the IKK/IκBα/NF-κB cascade that drives neuroinflammation, linking NCALD level to pro-inflammatory cytokine output.

   Evidence AAV-mediated silencing and overexpression with rescue in a CUMS rat model, with fractionated western blotting and cytokine ELISA

   PMID:33578182

   Open questions at the time

   • Direct molecular link between NCALD and IKK activation not demonstrated
   • Single-lab model; not independently replicated
   • Mechanism of NCALD-dependent pathway engagement unknown
4. 2025 Medium

   Tested whether NCALD controls hippocampal apoptosis and depressive behavior via sGC/cGMP/PKG signaling, placing NCALD upstream of caspase-3-mediated apoptosis and showing its overexpression abolishes antidepressant drug effects.

   Evidence AAV-mediated silencing and overexpression with rescue in a CUMS rat model, western blotting, cGMP ELISA, and behavioral assays

   PMID:41429623

   Open questions at the time

   • Direct biochemical connection between NCALD and sGC remains undefined
   • Single-lab finding in one disease model
   • Relationship between the NF-κB and sGC/cGMP/PKG branches not integrated
5. 2024 Low

   Probed the biochemical behavior of NCALD as a calcium sensor by showing it binds insulin in a Ca2+-inhibited manner, distinguishing it from the Ca2+-enhanced binding of the related sensor NCS-1.

   Evidence In vitro biophysical characterization (fluorescence spectroscopy, circular dichroism, size exclusion chromatography, analytical ultracentrifugation) (preprint)

   PMID:bio_10.1101_2024.07.26.605271

   Open questions at the time

   • Preprint without peer review
   • No cellular or functional validation of the insulin interaction
   • Physiological significance of Ca2+-dependent insulin binding unknown

• The core molecular function of NCALD as a calcium sensor — its direct effector targets and the mechanism connecting its calcium-binding to SMA, neuroinflammation, and apoptosis phenotypes — remains unresolved.
• No direct molecular partner or substrate established
• No structural model of calcium-dependent conformational switching
• Mechanistic unity across SMA, inflammation, and apoptosis phenotypes not demonstrated